Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Guokang Pharmaceutical is a comprehensive pharmaceutical enterprise based in Chengdu, China, focused on the R&D, production, and sale of chemical drugs. The company maintains a robust portfolio of generic medications, particularly in the cardiovascular, anti-infective, and metabolic therapeutic areas. With GMP-certified manufacturing facilities, Guokang produces a variety of dosage forms including tablets, capsules, and granules. The company serves both the domestic Chinese healthcare market and engages in the export of pharmaceutical products. Its core products include widely used treatments such as amlodipine besylate for hypertension and various broad-spectrum antibiotics. It is a key industrial player within the Chengdu Medical City ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Guokang Pharmaceutical.